Cancer Hospital of Chinese Academy of Medical Sciences

Beijing, Beijing Municipality 100021

0 studies enrolling now · 3 studies all time

What they study most

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Nasopharyngeal Carcinoma, Non Hodgkin Lymphoma, Renal Cell Carcinoma

Studies at this site

• Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. — Stopped early
• Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression — Completed
• Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001) — Stopped early